Squalene Market

Squalene Market Size & Trends (2023-2028):

The squalene Market was estimated to reach USD 285 million by 2028 from USD 180 million in 2022, at a compound annual growth rate of 9.10% over the calculated period.

The major factors driving growth in the squalene market is the rising demand from the cosmetics and pharmaceutical industry coupled with the awareness regarding the beneficial properties of squalene on human health. Increasing Research and development in the oncology segment along with increasing spending on oncology medicines is touted to fuel this industry in the coming days.

In India and China, there is stable growth in the cosmetics business. The main aspects responsible for the quickly increasing cosmetics industry in this area are the growing disposable income and the influence of the Western standard of living. The main driving factor for the cosmetic market amongst middle-aged women is that cosmetic manufacturers are commencing an extensive variety of anti-aging creams.

Drivers in the Squalene Market

The global squalene market size was esteemed at USD 111.9 million in the review period and is relied upon to observe consistent development as a result of rising awareness with respect to its medical advantages. This has brought about its expanding use in drugs, food enhancements, and beautifying agents. Squalene is a synthetic compound normally found in shark liver oil and other vegetable sources, including olive oil, rice grain oil, and raw grain oil. The market is supposed to develop considerably over the conjecture period as a result of its dietary and medical advantages, for example, white platelet restoration, immune system stimulation, anti-carcinogen, and antioxidant properties.

Expanding use of the item as a purifying and saturating compound in close-to-home consideration and restorative items, for example, creams, salves, lipsticks, shower oils, sunscreens, hair conditioners, and establishments will move industry development over the anticipated time frame. Squalene is immediately absorbed into the skin without leaving an oily residue and blends well in with different oils, which will enlarge its interest in personal care and cosmetic items. The development of the cosmetics industry can be credited to variables, for example, rising interest in organic and natural ingredients and appealing marketing and packaging strategies by multinationals. These variables are probably going to advance this industry extension. The high predominance of cancer growth and cardiovascular infections is foreseen to drive interest in squalene in drug applications as it lessens cancer-causing agents and cholesterol levels.

Restraints in the Squalene Market:

Fluctuation in crude material supply as a result of stringent government guidelines on shark poaching and wellbeing controversies identified with the utilization of squalene in drugs is likely to hamper development over the conjecture time frame.

Opportunities in the Squalene Market:

Growth and advancements in extraction strategies, combined with the improvement of vegetable and synthetic sources, are foreseen to positively affect the squalene market. Recent utilization of the item as a vaccine applicable in Europe to stimulate the human body's immune reaction is predicted to give a further boost to this market development in the future. Squalene also has medicinal features, making it a part of treatment in some cancers, which will support the demand going ahead in this business. The rising developments in the pharmaceutical sector is expected to provide new growth opportunities for the Squalene market, as it is the biggest end-user application. The increasing cosmetics sector in several developing nations coupled with the consumer demand for quality rich personal care products is supposed to drive the call for squalene in the foreseen years.

Challenges in the Squalene Market:

The consumer concerns related to the usage of animal-based products is estimated to pose a serious threat to the development of the global squalene market in the projection period. As squalene is primarily obtained from sharks, there are chances of overfishing of sharks, disturbing the aquatic ecosystem. This is also likely to impede the developments in the squalene industry in the coming years.

SQUALENE MARKET REPORT COVERAGE

The squalene Market is Segmented into the following categories as per the research report until 2028.

Squalene Market - By Source:

• Shark Liver

• Vegetable

• Synthetic Biotechnology

The animal source is estimated during the forecast period to dominate the squalene market. In squalene, Shark liver oil will remain the richest natural source. The dominance of animal sources is mostly because the price for squalene obtained from animal sources is less than that of squalene obtained from vegetables and other sources.

Squalene Market - By End-use Industry:

• Cosmetics

• Skin Care

• Hair Care

• Fragrance

• Food Supplements

• Cancer Treatment

• Heart Disease

By end-use industry, the cosmetics segment is estimated during the outlook period to register the highest growth in terms of value and volume of the global squalene market.

Squalene Market - By Region:

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle east and Africa

Europe is estimated to account for the largest share in the squalene market in terms of value in the future. This is owing to the increasing demand for squalene from the pharmaceuticals segment and nutraceutical segments in its countries. In the regional segment, the high spending power of consumers, as well as the growing demand for natural cosmetics with good quality products, is driving the growth of squalene in Europe

Squalene Market Key Players playing a major role are,

1. Sophim (France)

2. Amyris (US)

3. Kishimoto Special Liver Oil Co. Ltd. (Japan)

4. SeaDragon Marine Oils Limited (New Zealand

5. Nucelis LLC (US)

6. Arista Industries Inc. (US)

7. Ekiz Olive Oil & Soap Inc. (Turkey)

8. Empresa Figueirense De Pesca, Lda (Portugal)

9. Arbee BiomarineExtracts Pvt. Ltd. (India)

10. New Zealand GreenHealth Limited (New Zealand)